Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2018

Open Access 01-12-2018 | Research

Systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease

Authors: Grammati Sarri, Menaka Bhor, Seye Abogunrin, Caroline Farmer, Savita Nandal, Rashid Halloway, Dennis A. Revicki

Published in: Health and Quality of Life Outcomes | Issue 1/2018

Login to get access

Abstract

Background

Sickle cell disease (SCD) is a chronic condition associated with high mortality and morbidity. It is characterized by acute clinical symptoms such as painful vaso-occlusive crises, which can impair health-related quality of life (HRQL). This study was conducted to identify validated patient-reported outcome (PRO) instruments for use in future trials of potential treatments for SCD.

Methods

A systematic literature review (SLR) was performed using MEDLINE and EMBASE to identify United States (US)-based studies published in English between 1997 and 2017 that reported on validated PRO instruments used in randomized controlled trials and real-world settings. The COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist was used to assess the quality of PRO instruments.

Results

The SLR included 21 studies assessing the psychometric properties of 24 PRO instruments. Fifteen of those instruments were developed and validated for adults and 10 for children (one instrument was used in both children and young adults aged up to 21 years). Only five of the 15 adult instruments and three of the 10 pediatric instruments were developed specifically for SCD. For most instruments, there were few or no data on validation conducted in SCD development cohorts. Of the 24 PRO instruments identified, 16 had strong internal reliability (Cronbach’s α ≥0.80). There was often insufficient information to assess the content validity, construct validity, responsiveness, or test-retest reliability of the instruments identified for both child and adult populations. No validated PRO instruments measuring caregiver burden in SCD were identified.

Conclusions

The evidence on the psychometric properties of PRO instruments was limited. However, the results of this SLR provide key information on such tools to help inform the design of future clinical trials for patients with SCD in the US.
Appendix
Available only for authorised users
Literature
1.
Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, Jordan L, Lanzkron SM, Lottenberg R, Savage WJ. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312:1033–48.CrossRefPubMed
2.
3.
Schatz J, Puffer ES. Neuropsychological aspects of sickle cell disease. In: Brown RT, editor. Comprehensive Handbook of Childhood Cancer and Sickle Cell Disease: A Biopsychosocial Approach. New York: Oxford University Press; 2006. p. 449–70.
4.
5.
Hsieh MM, Kang EM, Fitzhugh CD, Link MB, Bolan CD, Kurlander R, Childs RW, Rodgers GP, Powell JD, Tisdale JF. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med. 2009;361:2309–17.CrossRefPubMedPubMedCentral
6.
Kamani NR, Walters MC, Carter S, Aquino V, Brochstein JA, Chaudhury S, Eapen M, Freed BM, Grimley M, Levine JE. Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the blood and marrow transplant clinical trials network (BMT CTN). Biology of Blood and Marrow Transplantation. 2012;18:1265–72.CrossRefPubMedPubMedCentral
7.
Locatelli F, Kabbara N, Ruggeri A, Ghavamzadeh A, Roberts I, Li CK, Bernaudin F, Vermylen C, Dalle J-H, Stein J. Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling. Blood. 2013;122:1072–8.CrossRefPubMed
8.
Wang WC, Ware RE, Miller ST, Iyer RV, Casella JF, Minniti CP, Rana S, Thornburg CD, Rogers ZR, Kalpatthi RV. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet. 2011;377:1663–72.CrossRefPubMedPubMedCentral
9.
Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med. 1995;332:1317–22.CrossRefPubMed
10.
11.
12.
Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. [updated March 2011]. The Cochrane Collaboration, 2011. Available from http://​handbook.​cochrane.​org.
13.
14.
15.
16.
US Department of Health, Evaluation HSFCfD, research, US Department of Health, evaluation HSFCfB, research, US Department of Health, human services FDA Center for devices, radiological health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:1–20.CrossRef
17.
Cooper-Effa M, Blount W, Kaslow N, Rothenberg R, Eckman J. Role of spirituality in patients with sickle cell disease. J Am Board Fam Pract. 2001;14:116–22.PubMed
18.
Edwards R, Telfair J, Cecil H, Lenoci J. Reliability and validity of a self-efficacy instrument specific to sickle cell disease. Behav Res Ther. 2000;38:951–63.CrossRefPubMed
19.
Evensen CT, Treadwell MJ, Keller S, Levine R, Hassell KL, Werner EM, Smith WR. Quality of care in sickle cell disease: cross-sectional study and development of a measure for adults reporting on ambulatory and emergency department care. Medicine. 2016;95:e4528.CrossRefPubMedPubMedCentral
20.
Jenerette C, Brewer CA, Crandell J, Ataga KI. Preliminary validity and reliability of the sickle cell disease health-related stigma scale. Issues in mental health nursing. 2012;33:363–9.CrossRefPubMed
21.
Jenerette C, Dixon J. Developing a short form of the simple Rathus assertiveness schedule using a sample of adults with sickle cell disease. J Transcult Nurs. 2010;21:314–24.CrossRefPubMed
22.
Jenerette CM, Valrie CR. The influence of maternal behaviors during childhood on self-efficacy in individuals with sickle cell disease. J Fam Nurs. 2010;16:422–34.CrossRefPubMed
23.
Jha A, Suarez ML, Ferrans CE, Molokie R, Kim YO, Wilkie DJ. Cognitive testing of PAINReportIt® in adult African Americans with sickle cell disease. Computers, informatics, nursing: CIN. 2010;28:141.CrossRefPubMedPubMedCentral
24.
Keller SD, Yang M, Treadwell MJ, Werner EM, Hassell KL. Patient reports of health outcome for adults living with sickle cell disease: development and testing of the ASCQ-me item banks. Health Qual Life Outcomes. 2014;12:125.CrossRefPubMedPubMedCentral
25.
Sobota A, Akinlonu A, Champigny M, Eldridge M, McMahon L, Telfair J, Sprinz P. Self-reported transition readiness among young adults with sickle cell disease. J Pediatr Hematol Oncol. 2014;36:389.CrossRefPubMedPubMedCentral
26.
Zempsky WT, O'Hara EA, Santanelli JP, Palermo TM, New T, Smith-Whitley K, Casella JF. Validation of the sickle cell disease pain burden interview–youth. J Pain. 2013;14:975–82.CrossRefPubMedPubMedCentral
27.
Clay OJ, Telfair J. Evaluation of a disease-specific self-efficacy instrument in adolescents with sickle cell disease and its relationship to adjustment. Child Neuropsychology. 2007;13:188–203.CrossRefPubMed
28.
Dampier C, Lieff S, LeBeau P, Rhee S, McMurray M, Rogers Z, Smith-Whitley K, Wang W. Health-related quality of life in children with sickle cell disease: a report from the comprehensive sickle cell centers clinical trial consortium. Pediatr Blood Cancer. 2010;55:485–94.CrossRefPubMedPubMedCentral
29.
Dampier C, Barry V, Gross HE, Lui Y, Thornburg CD, DeWalt DA, Reeve BB. Initial evaluation of the pediatric PROMIS® health domains in children and adolescents with sickle cell disease. Pediatr Blood Cancer. 2016;63:1031–7.CrossRefPubMedPubMedCentral
30.
Gil KM, Wilson JJ, Edens JL. The stability of pain coping strategies in young children, adolescents, and adults with sickle cell disease over an 18-month period. Clin J Pain. 1997;13:110–5.CrossRefPubMed
31.
Gupta N, Naegeli AN, Turner-Bowker DM, Flood EM, Heath LE, Mays SM, Dampier C. Cognitive testing of an electronic version of the faces pain scale-revised with pediatric and adolescent sickle cell patients. The Patient-Patient-Centered Outcomes Research. 2016;9:433–43.CrossRefPubMed
32.
Karlson CW, Leist-Haynes S, Smith M, Faith MA, Elkin TD, Megason G. Examination of risk and resiliency in a pediatric sickle cell disease population using the psychosocial assessment tool 2.0. J Pediatr Psychol. 2012;37:1031–40.CrossRefPubMed
33.
McClellan CB, Schatz J, Sanchez C, Roberts CW. Validity of the pediatric quality of life inventory for youth with sickle cell disease. J Pediatr Psychol. 2008;33:1153–62.CrossRefPubMed
34.
Panepinto JA, Pajewski NM, Foerster LM, Hoffmann RG. The performance of the PedsQL™ generic Core scales in children with sickle cell disease. J Pediatr Hematol Oncol. 2008;30:666.CrossRefPubMedPubMedCentral
35.
Panepinto JA, Torres S, Bendo CB, McCavit TL, Dinu B, Sherman-Bien S, Bemrich-Stolz C, Varni JW. PedsQL™ multidimensional fatigue scale in sickle cell disease: feasibility, reliability, and validity. Pediatr Blood Cancer. 2014;61:171–7.CrossRefPubMed
36.
Panepinto JA, Torres S, Bendo CB, McCavit TL, Dinu B, Sherman-Bien S, Bemrich-Stolz C, Varni JW. PedsQL™ sickle cell disease module: feasibility, reliability, and validity. Pediatr Blood Cancer. 2013;60:1338–44.CrossRefPubMedPubMedCentral
37.
Zempsky WT, O'Hara EA, Santanelli JP, New T, Smith-Whitley K, Casella J, Palermo TM. Development and validation of the youth acute pain functional ability questionnaire (YAPFAQ). J Pain. 2014;15:1319–27.CrossRefPubMedPubMedCentral
38.
Brogan AP, DeMuro C, Barrett AM, D’Alessio D, Bal V, Hogue SL. Payer perspectives on patient-reported outcomes in health care decision making: oncology examples. Journal of Managed Care & Specialty Pharmacy. 2017;23:125–34.CrossRef
39.
Zagadailov E, Fine M, Shields A. Patient-reported outcomes are changing the landscape in oncology care: challenges and opportunities for payers. American health & drug benefits. 2013;6:264.
40.
41.
42.
Patrick DL, Burke LB, Powers JH, Scott JA, Rock EP, Dawisha S, O'neill R, Kennedy DL. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health. 2007;10:S125–37.CrossRefPubMed
43.
Regnault A, Hamel J-F, Patrick DL. Pooling of cross-cultural PRO data in multinational clinical trials: how much can poor measurement affect statistical power? Qual Life Res. 2015;24:273–7.CrossRefPubMed
Metadata
Title
Systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease
Authors
Grammati Sarri
Menaka Bhor
Seye Abogunrin
Caroline Farmer
Savita Nandal
Rashid Halloway
Dennis A. Revicki
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2018
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-018-0930-y

Other articles of this Issue 1/2018

Health and Quality of Life Outcomes 1/2018 Go to the issue

Research

Development and validation of a new instrument to measure perceived risks associated with the use of tobacco and nicotine-containing products

Research

Fitness as mediator between weight status and dimensions of health-related quality of life

Short report

Assessing the reliability of the short form 12 (SF-12) health survey in adults with mental health conditions: a report from the wellness incentive and navigation (WIN) study

Research

Quality of life of men and women with gender identity disorder

Research

Development and content validation of a patient-reported endometriosis pain daily diary

Research

Life satisfaction among elderly patients in Nepal: associations with nutritional and mental well-being